73 related articles for article (PubMed ID: 24880093)
1. Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer.
Giannakakis A; Karapetsas A; Dangaj D; Lanitis E; Tanyi J; Coukos G; Sandaltzopoulos R
Int J Biochem Cell Biol; 2014 Aug; 53():389-98. PubMed ID: 24880093
[TBL] [Abstract][Full Text] [Related]
2. The homeodomain transcription factor MEIS1 triggers chemokine expression and is involved in CD8+ T-lymphocyte infiltration in early stage ovarian cancer.
Karapetsas A; Tokamani M; Evangelou C; Sandaltzopoulos R
Mol Carcinog; 2018 Sep; 57(9):1251-1263. PubMed ID: 29802738
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival.
Karapetsas A; Giannakakis A; Dangaj D; Lanitis E; Kynigopoulos S; Lambropoulou M; Tanyi JL; Galanis A; Kakolyris S; Trypsianis G; Coukos G; Sandaltzopoulos R
Biomed Res Int; 2015; 2015():712438. PubMed ID: 26448945
[TBL] [Abstract][Full Text] [Related]
4. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
5. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
7. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites.
Milliken D; Scotton C; Raju S; Balkwill F; Wilson J
Clin Cancer Res; 2002 Apr; 8(4):1108-14. PubMed ID: 11948121
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype.
Barnett JC; Bean SM; Whitaker RS; Kondoh E; Baba T; Fujii S; Marks JR; Dressman HK; Murphy SK; Berchuck A
Gynecol Oncol; 2010 Mar; 116(3):556-62. PubMed ID: 20006900
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of CD8
Wu M; Lou J; Zhang S; Chen X; Huang L; Sun R; Huang P; Pan S; Wang F
Cell Prolif; 2016 Dec; 49(6):669-677. PubMed ID: 27641758
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.
Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH
Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours.
Scotton C; Milliken D; Wilson J; Raju S; Balkwill F
Br J Cancer; 2001 Sep; 85(6):891-7. PubMed ID: 11556842
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
[TBL] [Abstract][Full Text] [Related]
14. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
16. Activated (HLA-DR+) T-lymphocyte subsets in early epithelial ovarian cancer and malignant ovarian germ cell tumors.
Miyazaki K; Shimada K; Katabuchi H; Arakane F; Arao S; Okamura H
Gynecol Oncol; 1995 Sep; 58(3):362-7. PubMed ID: 7672702
[TBL] [Abstract][Full Text] [Related]
17. [Detection of lymphocyte subsets in the peripheral blood of patients with malignant ovarian tumors].
Liu M; Xie J; Zhao S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):627-9, 634. PubMed ID: 24909286
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
19. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis.
Krockenberger M; Kranke P; Häusler S; Engel JB; Horn E; Nürnberger K; Wischhusen J; Dietl J; Hönig A
Anticancer Res; 2012 Dec; 32(12):5233-8. PubMed ID: 23225421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
